InvestorsHub Logo
Followers 1
Posts 160
Boards Moderated 0
Alias Born 10/17/2013

Re: sts66 post# 23036

Monday, 12/23/2013 12:28:40 PM

Monday, December 23, 2013 12:28:40 PM

Post# of 425916
sts66,

I agree it would be hard for a stock holder to sue. However, the company has the ability as they were party to the contract. In the end, I do not see how the FDA would have enough cover if the SPA isn't reinstated. My belief is the SPA will be reinstated but the anchor indication is not guaranteed. My question, with the FDA rescinding the SPA already for reasons that seem to breach the contract, will the reinstatement of the SPA give them enough cover if they reject anchor completely?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News